Fundraising FoxBoulevard Bio
1 known investors
Find your way into Boulevard Bio
Sign up to see every warm intro you have to Boulevard Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Boulevard Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Boulevard Bio is a clinical-stage precision immunology company developing multi-specific antibody therapies for B cell-driven autoimmune diseases, with a lead program targeting IgA nephropathy. Its pipeline aims to modify disease at the source for conditions such as IgAN, lupus, and Sjögren's disease.
Investors · 1
Frequently asked questions
- What does Boulevard Bio do?
- Boulevard Bio is a clinical-stage precision immunology company developing multi-specific antibody therapies for B cell-driven autoimmune diseases, with a lead program targeting IgA nephropathy. Its pipeline aims to modify disease at the source for conditions such as IgAN, lupus, and Sjögren's disease.
- Who are Boulevard Bio's investors?
- Boulevard Bio's investors include Deerfield Management Company.